Cellulite as a Possible Biomarker of Metabolic Dysfunction: Redefining Body Remodeling in the Glucagon-Like Peptide-1 Era Through the Cellulite Removal Medical Protocol-G21 Concept.

Adamidis N, Adamidi S, Georgakopoulou VE, Papadopoulou N, Adamidis S

Open source

DOI
10.7759/cureus.110805
Published
2026 Jun
Container
Cureus
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7759/cureus.110805,
  title = {Cellulite as a Possible Biomarker of Metabolic Dysfunction: Redefining Body Remodeling in the Glucagon-Like Peptide-1 Era Through the Cellulite Removal Medical Protocol-G21 Concept.},
  author = {Adamidis N and Adamidi S and Georgakopoulou VE and Papadopoulou N and Adamidis S},
  year = {2026},
  journal = {Cureus},
  doi = {10.7759/cureus.110805},
  url = {https://doi.org/10.7759/cureus.110805}
}

RIS

TY  - JOUR
TI  - Cellulite as a Possible Biomarker of Metabolic Dysfunction: Redefining Body Remodeling in the Glucagon-Like Peptide-1 Era Through the Cellulite Removal Medical Protocol-G21 Concept.
AU  - Adamidis N
AU  - Adamidi S
AU  - Georgakopoulou VE
AU  - Papadopoulou N
AU  - Adamidis S
PY  - 2026
JO  - Cureus
DO  - 10.7759/cureus.110805
UR  - https://doi.org/10.7759/cureus.110805
ER  - 

APA

N, A., S, A., VE, G., N, P., & S, A. (2026). Cellulite as a Possible Biomarker of Metabolic Dysfunction: Redefining Body Remodeling in the Glucagon-Like Peptide-1 Era Through the Cellulite Removal Medical Protocol-G21 Concept.. Cureus. https://doi.org/10.7759/cureus.110805

Source records